BackMoonLake Immunotherapeutics Overview

MoonLake Immunotherapeutics Other Current Assets

Latest other current assets for MLTX: $26M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$26.45M
2.01% YoYΔ $-542000.00 vs prior year quarter

Peer average / median

Loading

MoonLake Immunotherapeutics Other Current Assets History

Loading

MoonLake Immunotherapeutics vs. peers: Other Current Assets Comparison

Loading

MoonLake Immunotherapeutics Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

MoonLake Immunotherapeutics (MLTX) FAQ

As of the most recent data (June 2026), MLTX shows a other current assets of $26M. That compares with $27M in the prior-year period — down 2.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MLTX's other current assets is now $26M (was $27M) — a 2.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether MoonLake Immunotherapeutics is outperforming or lagging.

Tracking MLTX's other current assets over time shows whether MoonLake Immunotherapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $26M That compares with $27M in the prior-year period — down 2.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has MoonLake Immunotherapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $26M) with ownership activity and broader fundamentals.